BY THE DIGITAL HEALTH LEADERS FOR THE DIGITAL HEALTH COMMUNITY
BY THE DIGITAL HEALTH LEADERS 
Dr Reddy's, Cipla, Glenmark, Biocon, & Wockhardt Grabbed INR 25,813 Cr under PLI Schemes April 1, 2024 The PLI schemes, with an INR 1.97 Lakh Cr outlay across 14 sectors, aim to boost investments, drive innovation, and improve competitiveness in key industries.
MedGenome Collaborates with Darshan GIVA Foundation to Advance TB Diagnosis March 21, 2024 MedGenome, a leading genomics company in South Asia, has joined forces with Darshan GIVA Foundation, a non-governmental organization, in a significant move towards improving tuberculosis (TB) diagnosis and treatment.
Engrail Therapeutics Closes ‘Oversubscribed’ Series B Funding Round with $157 Mn March 20, 2024 The latest capital infusion will be used to propel Engrail's pipeline forward, facilitating progress through various stages of clinical development, the drugmaker said.
Pharmexcil DG Urges Member Companies to Avail PTUAS Scheme March 19, 2024 With a focus on quality enhancement and capacity building, the scheme aligns with broader objectives to foster innovation and excellence within the pharmaceutical industry.
Delhi HC Grants 2 Months as ‘Final Opportunity’ to Frame Online Medicine Policy March 18, 2024 The extension was permitted on the grounds that the issue was "complex" and any modification in the manner of the sale of drugs would have far-reaching consequences.
US & Indian Pharmacopoeia Commission Ink MoU for Pharma Safety Globally March 18, 2024 The partnership aims to fortify pharmaceutical standards and enhance the global supply chain for safe and reliable medicines.
Pandorum Technologies Bags $11 Mn Pre-Series B Funding March 18, 2024 The infusion of fresh funds will be utilized to advance Pandorum’s technology platform for liver, lung, and neuronal tissue regeneration.
Eris Lifesciences Acquires Biocon Biologics’ India Branded Formulation Biz for INR 1,242 Cr March 18, 2024 This strategic move aims to expand Eris's presence in the Indian market and venture into the lucrative injectables segment, valued at over INR 30,000 Cr.
DoP Revises PLI Schemes for Bulk Drugs & Medical Devices March 15, 2024 The Department of Pharmaceuticals (DoP) has announced revision of production-linked incentive (PLI) guidelines to promote manufacturing of bulk drugs and medical devices.
Govt Rolls Out Uniform Code for Pharmaceutical Marketing Practices 2024 March 14, 2024 Led by the Ministry of Chemicals and Fertilizers, this initiative aims to address misleading promotional activities and promote responsible marketing within the pharmaceutical sector.
DoP Forms Committee to Reform Drug Pricing Framework March 13, 2024 The objective is to strike a balance between ensuring the availability of essential medicines and incentivizing the industry for sustainable growth and exports.
DoP Revises PTUAS Guidelines to Support MSMEs March 12, 2024 The Department of Pharmaceuticals (DoP) has made substantial changes to the Pharmaceutical Technology Upgradation Assistance Scheme (PTUAS) sub-scheme, with a focus on aiding MSMEs in the pharmaceutical sector.
